Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

Ho AL; Rom Leidner; See full list of authors in comments

Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

Ho AL, Rom Leidner, See full list of authors in comments

Research output: Other contribution

Original language	Undefined/Unknown
State	Published - Nov 1 2023

Publication series

Name	Articles, Abstracts, and Reports

Access to Document

http://digitalcommons.providence.org/publications/8347

Cite this

@misc{91ff6c668c574b8cb79e801b77221884,

title = "Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study",

author = "Ho AL and Rom Leidner and comments, {See full list of authors in}",

year = "2023",

month = nov,

day = "1",

language = "Undefined/Unknown",

series = "Articles, Abstracts, and Reports",

type = "Other",

}

TY - GEN

T1 - Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

AU - AL, Ho

AU - Leidner, Rom

AU - comments, See full list of authors in

PY - 2023/11/1

Y1 - 2023/11/1

M3 - Other contribution

T3 - Articles, Abstracts, and Reports

ER -